Synaptogenix, Inc.

Synaptogenix, Inc.verified

SNPX

Price:

$7.85

Market Cap:

$11.90M

Synaptogenix, Inc. operates as a biopharmaceutical entity, actively advancing multiple product candidates through both preclinical and clinical development stages. The company's primary focus involves establishing a therapeutic platform centered on Bryostatin-1, a key drug candidate, primarily for the treatment of Alzheimer's disease. Additionally, Synaptogenix is exploring Bryostatin's potential applications for various other neurodegenerative or cognitive disorders and dysfunctions, including fragile X syndrome, multiple sclerosis, and Niemann-Pick type C disease. To facilitate its research and development, Synaptogenix holds licensing agreements with prominent institutions such as Stanfor...[Read more]

Industry

Biotechnology

IPO Date

2020-12-08

Stock Exchange

NASDAQ

Ticker

SNPX

The Enterprise Value as of June 2026 (TTM) for Synaptogenix, Inc. (SNPX) is 8.25M

According to Synaptogenix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.25M. This represents a change of -55.41% compared to the average of 18.50M of the last 4 quarters.

Synaptogenix, Inc. (SNPX) Historical Enterprise Value (quarterly & annually)

How has SNPX Enterprise Value performed in the past?

The mean historical Enterprise Value of Synaptogenix, Inc. over the last ten years is -20528647.00. The current 8.25M Enterprise Value has changed -4119.21% with respect to the historical average. Over the past ten years (40 quarters), SNPX's Enterprise Value was at its highest in in the March 2026 quarter at 38.93M. The Enterprise Value was at its lowest in in the March 2024 quarter at -22183157.00.

Quarterly (TTM)
Annual

Average

-20528647.00

Median

-26797098.00

Minimum

-36360208.00

Maximum

6.65M

Synaptogenix, Inc. (SNPX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Synaptogenix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 8.83%

Maximum Annual Enterprise Value = 6.65M

Minimum Annual Increase = -152.25%

Minimum Annual Enterprise Value = -36360208.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20256.65M-152.25%
2024-12721421.00-52.53%
2023-26797098.00-26.30%
2022-36360208.008.83%

Synaptogenix, Inc. (SNPX) Average Enterprise Value

How has SNPX Enterprise Value performed in the past?

The current Enterprise Value of Synaptogenix, Inc. (SNPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-10957151.33

5-year avg

-20528647.00

10-year avg

-20528647.00

Synaptogenix, Inc. (SNPX) Enterprise Value vs. Peers

How is SNPX’s Enterprise Value compared to its peers?

Synaptogenix, Inc.’s Enterprise Value is less than Korro Bio, Inc. (96.75M), less than Scorpius Holdings, Inc. (17.55M), greater than Applied Molecular Transport Inc. (-14017713.00), greater than ObsEva S.A. (5.60M), greater than Cyclacel Pharmaceuticals, Inc. (-1631385.00), greater than Notable Labs, Ltd. (-7381410.00), less than Gelesis Holdings, Inc. (66.48M), less than TuHURA Biosciences, Inc. (141.90M), greater than Apexigen, Inc. (-5121682.00),

CompanyEnterprise ValueMarket cap
96.75M$115.56M
17.55M$13.63K
-14017713.00$11.01M
5.60M$11.00M
-1631385.00$10.61M
-7381410.00$2.39M
66.48M$11.63M
141.90M$147.74M
-5121682.00$9.57M

Build a custom stock screener for Synaptogenix, Inc. (SNPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synaptogenix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Synaptogenix, Inc. (SNPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Synaptogenix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Synaptogenix, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Synaptogenix, Inc. (SNPX)?

What is the 3-year average Enterprise Value for Synaptogenix, Inc. (SNPX)?

What is the 5-year average Enterprise Value for Synaptogenix, Inc. (SNPX)?

How does the current Enterprise Value for Synaptogenix, Inc. (SNPX) compare to its historical average?